Armata Pharmaceuticals (ARMP) Research & Development (2016 - 2026)
Quarterly results put Research & Development at $6.1 million for Q1 2026, up 12.56% from a year ago — trailing twelve months through Mar 2026 was $24.4 million (down 23.37% YoY), and the annual figure for FY2025 was $23.7 million, down 31.11%.
Armata Pharmaceuticals has reported Research & Development over the past 14 years, most recently at $6.1 million for Q1 2026.
- Research & Development reached $6.1 million in Q1 2026 per ARMP's latest filing, up from $6.1 million in the prior quarter.
- Across five years, Research & Development topped out at $9.6 million in Q1 2023 and bottomed at $5.4 million in Q1 2025.
- Median Research & Development over the past 5 years was $8.0 million (2022), compared with a mean of $7.8 million.
- The largest annual shift saw Research & Development skyrocketed 98.77% in 2022 before it tumbled 38.6% in 2025.
- Over 5 years, Research & Development stood at $9.6 million in 2022, then fell by 17.15% to $7.9 million in 2023, then grew by 6.6% to $8.5 million in 2024, then dropped by 28.17% to $6.1 million in 2025, then grew by 0.68% to $6.1 million in 2026.
- Business Quant data shows Research & Development for ARMP at $6.1 million in Q1 2026, $6.1 million in Q4 2025, and $5.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 1.54 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -2.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 6.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.11 Mn |
| Dec 31, 2025 | 6.07 Mn |
| Sep 30, 2025 | 5.82 Mn |
| Jun 30, 2025 | 6.39 Mn |
| Mar 31, 2025 | 5.43 Mn |
| Dec 31, 2024 | 8.45 Mn |
| Sep 30, 2024 | 9.49 Mn |
| Jun 30, 2024 | 8.48 Mn |
| Mar 31, 2024 | 8.02 Mn |
| Dec 31, 2023 | 7.93 Mn |
| Sep 30, 2023 | 7.98 Mn |
| Jun 30, 2023 | 8.26 Mn |
| Mar 31, 2023 | 9.60 Mn |
| Dec 31, 2022 | 9.57 Mn |
| Sep 30, 2022 | 8.40 Mn |
| Jun 30, 2022 | 9.02 Mn |
| Mar 31, 2022 | 8.03 Mn |
| Dec 31, 2021 | 4.81 Mn |
| Sep 30, 2021 | 5.63 Mn |
| Jun 30, 2021 | 5.23 Mn |
| Mar 31, 2021 | 4.35 Mn |
| Dec 31, 2020 | 4.98 Mn |
| Sep 30, 2020 | 4.07 Mn |
| Jun 30, 2020 | 2.65 Mn |
| Mar 31, 2020 | 2.75 Mn |
| Dec 31, 2019 | 1.32 Mn |
| Sep 30, 2019 | 3.02 Mn |
| Jun 30, 2019 | 3.08 Mn |
| Mar 31, 2019 | 2.06 Mn |
| Dec 31, 2018 | 1.98 Mn |
| Sep 30, 2018 | 1.92 Mn |
| Jun 30, 2018 | 2.29 Mn |
| Mar 31, 2018 | 1.46 Mn |
| Dec 31, 2017 | 1.09 Mn |
| Jun 30, 2017 | 1.13 Mn |
| Mar 31, 2017 | 1.49 Mn |
| Dec 31, 2016 | 5.55 Mn |
| Sep 30, 2016 | 41,000.00 |
| Jun 30, 2016 | 1.24 Mn |